Newsbenzinga
Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout
· Published
Article summary
Pacira BioSciences stock surges 44% after Viatris announces a $1.65 billion takeover deal to expand its pain treatment portfolio.
An excerpt from the original article.
Comments —
Loading comments…